Skip to main content
. 2018 Sep 10;10(9):322. doi: 10.3390/cancers10090322

Figure 1.

Figure 1

Biochemical control rates between HDR-BT monotherapy and IG-IMRT with helical tomotherapy: (a) total population; (b) low-risk group; (c) intermediate-risk group; (d) high-risk group; (e) very-high-risk group.